Skip to content

Mirum Pharmaceuticals

US · MIRM #2051 by market cap Listed 2019
96.13 +0.62 +0.65%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 6 in the most recent period (2026/Q3).
  • Total institutional ownership rose 2.0 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
114.86% +2.04pp
Institutions
413 +6
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund80.09%
VC/PE Fund16.72%
Hedge Fund11.57%
Public Company3.14%
Private Company1.66%
Individual/Insider1.33%
Government Pension Fund0.69%
Insurance Company0.32%
Endowment Fund0.31%
Sovereign Wealth Fund0.30%

Top holders as of 2026-06-30

Frazier Life Sciences Management, LP 11.76% · 7.68M sh
Janus Henderson Group plc 9.05% · 5.91M sh
BlackRock 7.24% · 4.72M sh
FMR 6.24% · 4.07M sh
T. Rowe Price Group, Inc. 4.07% · 2.66M sh
Vanguard Portfolio Management, LLC 4.03% · 2.63M sh
Vanguard Capital Management, LLC 3.83% · 2.50M sh
State Street Global Advisors 3.66% · 2.39M sh
Geode Capital Management, LLC 2.22% · 1.45M sh
William Blair Investment Management, LLC 2.18% · 1.42M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 26 buys · 23 sells

NameRoleStake
Frazier Life Sciences Management, LP -- 11.76%
Christopher Peetz Chief Executive Officer 0.60%
Michael Grey Independent Non-Executive Chairperson 0.43%
Peter Radovich Chief Operating Officer 0.09%
Eric Bjerkholt Chief Financial Officer 0.07%
Joanne M. Quan Former Chief Medical Officer 0.03%
Jolanda Howe Senior VP & Global Controller 0.03%
Laura Brege Independent Director 0.02%
Laurent Fischer Independent Director 0.02%
Lon Cardon Independent Director 0.01%
Timothy Walbert Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-10 Laura Brege Independent Director Derivative Exercise and Sale -14,167 $16.71–94.74
2026-11-03 Joanne M. Quan Former Chief Medical Officer Intent to Sell (Form 144) -14,684 $96.97
2026-11-03 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $2.94–90.00
2026-10-15 Jolanda Howe Senior VP & Global Controller Derivative Exercise and Retained +16,112 $19.24
2026-10-08 Rob Myers Chief Medical Officer Other Derivative Acquisition +25,000 --
2026-10-08 Rob Myers Chief Medical Officer Other Derivative Acquisition +40,000 $86.01
2026-10-05 Christopher Peetz Chief Executive Officer Derivative Exercise and Retained +12,197 $15.87–19.19
2026-09-20 Rob Myers Chief Medical Officer Initial Statement of Beneficial 0 --
2026-09-13 Eric Bjerkholt Chief Financial Officer Derivative Exercise and Sale -9,943 $98.37
2026-09-13 Eric Bjerkholt Chief Financial Officer Intent to Sell (Form 144) -9,943 $98.37
2026-09-10 Eric Bjerkholt Chief Financial Officer Derivative Exercise and Retained +8,390 --
2026-09-01 Jolanda Howe Senior VP & Global Controller Automatic Disposition -658 $100.00
2026-08-31 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -30,000 $2.94–98.91
2026-08-17 Jolanda Howe Senior VP & Global Controller Derivative Exercise and Sale -40,000 $6.27–100.00
2026-08-10 Eric Bjerkholt Chief Financial Officer Automatic Disposition -6,001 $99.90
2026-08-09 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $2.94–100.14
2026-08-02 Jolanda Howe Senior VP & Global Controller Automatic Disposition -1,840 $105.29
2026-07-05 Eric Bjerkholt Chief Financial Officer Automatic Disposition -5,000 $121.67–124.94
2026-07-05 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $2.94–124.79
2026-06-30 Jolanda Howe Senior VP & Global Controller Automatic Disposition -2,721 $120.00

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mirum Pharmaceuticals discussion 0 comments

Add a comment